Loading...
Loading...
Contributors:
Dataset URI:
109f642c-2873-4bac-807e-c4e4fb9b7d32The aim of the study is to describe the immunogenicity and safety of the new formulation of Quadrivalent Influenza Vaccine (QIV) for the 2013-2014 season in the Northern Hemisphere (NH) in subjects aged 9 to 17 years in Taiwan Primary Objective: - To describe the immunogenicity of the QIV (split-virion, inactivated) NH seasonal formulation Secondary Objective: - To describe the safety of the QIV (split-virion, inactivated) NH seasonal formulation
Keyword(s):
Healthy; Infectious Disease; Influenza; Influenza Virus Vaccine; Quadrivalent Influenza Vaccine (split virion, inactivated).
MeSH Term(s):
Grants and Funding:
Associated Publication(s):
No Associated Publication Data Available
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)